USFDA completes inspection at Sterile Injectable site of Caplin Point Laboratories’ arm

01 Jun 2023 Evaluate

United States Food and Drug Administration (USFDA) has completed its GMP and PAI inspection at Caplin Point Laboratories’ subsidiary -- Caplin Steriles’ Sterile Injectable site at Gummidipoondi between May 22, 2023 to May 31, 2023. 

At the end of the inspection, there were four observations by USFDA. These observations are procedural in nature and the corrective and preventive actions for these observations will be presented to the US FDA within the stipulated period. The observations made were not repeat observations or related to data integrity.

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.

Caplin Point Lab Share Price

1918.15 -50.20 (-2.55%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×